Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia

被引:64
作者
Hashimoto, Kenji [1 ]
Shimizu, Eiji [1 ]
Iyo, Masaomi [1 ]
机构
[1] Chiba Univ Grad Sch Med, Dept Psychiat, 1-8-1 Inohana, Chiba 2608670, Japan
关键词
NMDA receptor; growth factors; neurotrophic factors; cytokines; D-serine; schizophrenia;
D O I
10.2174/1573400054065569
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Multiple lines of evidence suggest that genetic factors and environmental factors as well as a dysfunction in the glutamatergic neurotransmission contribute to the pathophysiology of schizophrenia. Communication between neurons and glia is essential for axonal conduction, synaptic neurotransmission, and information processing, and thus is required for normal functioning of the nervous system during development and throughout adult life. A number of studies have demonstrated that the substances which communicate between neurons and glia are altered in the blood, cerebrospinal fluid (CSF), and postmortem brain samples of schizophrenic patients. These findings suggest that neuron-glia communication might be impaired in the brains of schizophrenic patients. In this article, we review the imbalance of neuron-glia communication presented in the neurodevelopmental hypothesis as well as the glutamate hypothesis of schizophrenia. First, we discuss the role of growth factors (e.g., basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), midkine), brain-derived neurotrophic factor (BDNF) and cytokines in the pathophysiology of schizophrenia. Second, we focus on the role of endogenous substances (glutamate, glutamine, D-serine, kynurenic acid, and glutathione), which modulate the NMDA receptor function, in the pathophysiology of schizophrenia.
引用
收藏
页码:151 / 163
页数:13
相关论文
共 168 条
[81]   NEUROTROPHIC FACTORS - FROM MOLECULE TO MAN [J].
LINDSAY, RM ;
WIEGAND, SJ ;
ALTAR, CA ;
DISTEFANO, PS .
TRENDS IN NEUROSCIENCES, 1994, 17 (05) :182-190
[82]   NEUROTROPHINS AND BRAIN INSULTS [J].
LINDVALL, O ;
KOKAIA, Z ;
BENGZON, J ;
ELMER, E ;
KOKAIA, M .
TRENDS IN NEUROSCIENCES, 1994, 17 (11) :490-496
[83]   BDNF and activity-dependent synaptic modulation [J].
Lu, B .
LEARNING & MEMORY, 2003, 10 (02) :86-98
[84]   STUDY OF A NEW SCHIZOPHRENOMIMETIC DRUG - SERNYL [J].
LUBY, ED ;
COHEN, BD ;
ROSENBAUM, G ;
GOTTLIEB, JS ;
KELLEY, R .
ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1959, 81 (03) :363-369
[85]   Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: Effects of antipsychotic drugs [J].
Maes, M ;
Bosmans, E ;
Ranjan, R ;
Vandoolaeghe, E ;
Meltzer, HY ;
DeLey, M ;
Berghmans, R ;
Stans, G ;
Desnyder, R .
SCHIZOPHRENIA RESEARCH, 1996, 21 (01) :39-50
[86]  
Magistretti PJ, 2003, NEUROPSYCHOPHARMACOL, P703
[87]  
Meador-Woodruff JH, 2003, NEUROPSYCHOPHARMACOL, P717
[88]   The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia [J].
Moises, Hans W. ;
Zoega, Tomas ;
Gottesman, Irving I. .
BMC PSYCHIATRY, 2002, 2 (1)
[89]   Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino-acid oxidase activity [J].
Morikawa, A ;
Hamase, K ;
Inoue, T ;
Konno, R ;
Niwa, A ;
Zaitsu, K .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2001, 757 (01) :119-125
[90]   TROPHIC STIMULATION OF CULTURED NEURONS FROM NEONATAL RAT-BRAIN BY EPIDERMAL GROWTH-FACTOR [J].
MORRISON, RS ;
KORNBLUM, HI ;
LESLIE, FM ;
BRADSHAW, RA .
SCIENCE, 1987, 238 (4823) :72-75